RESTON, Va. - (Business Wire)
QuadraMed® Corporation (Amex:QD) today named Julian A.L. Allen to its Board of Directors, expanding the Board from five to six members. Mr. Allen is the Founder of Spitfire Capital LLC, a San Francisco-based investment advisor, and Managing Partner of The Spitfire Fund LP, which owns 560,600 shares of QuadraMed
’s common stock, representing approximately 1.3% of the Company
’s outstanding common stock.
"Julian’s deep financial and investment expertise, as well as his in-depth knowledge of QuadraMed, provides him with a unique perspective,” said Keith Hagen, QuadraMed’s president and CEO. “We are delighted to welcome Julian to our Board and anticipate that his Wall Street experience will be invaluable as we execute on our growth strategies and expand our investor relations initiatives.”
“QuadraMed is a leader in providing information technology solutions that improve clinical and financial outcomes for healthcare providers,” said Mr. Allen. “I am looking forward to working with the board of directors and management team to help QuadraMed leverage the many opportunities that lie ahead.”
Before founding Spitfire Capital, Mr. Allen was a member of Cannell Capital LLC and its affiliate, OneFifty LLC, a San Francisco hedge fund advisor. Prior to joining Cannell Capital, Mr. Allen was a Managing Director of J.H. Whitney & Co., LLC, a private equity and alternative investment management firm where he focused on private equity investments in the financial services, business services, healthcare services and technology industries. Previously, Mr. Allen held various positions at Capital Z Partners, Patricof & Co. Ventures, Inc., and Wasserstein Perella & Co., Inc. Mr. Allen received his Master of Business Administration degree with High Distinction from Harvard Business School and a Bachelor of Arts degree from Cambridge University.
About QuadraMed Corporation
QuadraMed Corporation advances the success of healthcare organizations through IT solutions that leverage quality care into positive financial outcomes. QuadraMed provides real world solutions that help healthcare professionals deliver outstanding patient care efficiently and cost effectively. Behind the company’s products and services is a staff of 650 professionals whose experience and dedication have earned QuadraMed the trust and loyalty of clients at over 2,000 healthcare provider facilities. For more information about QuadraMed, visit http://www.quadramed.com/.
Cautionary Statement on Risks Associated with QuadraMed Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 by QuadraMed that are subject to risks and uncertainties. The words "believe," "expect," "anticipate," "intend," "plan," "estimate," "may," "should," "could," and similar expressions are intended to identify such statements. Forward-looking statements are not guarantees of future performance and are to be interpreted only as of the date on which they are made. QuadraMed undertakes no obligation to update or revise any forward-looking statement except as required by law. QuadraMed advises investors that it discusses risk factors and uncertainties that could cause QuadraMed’s actual results to differ from forward-looking statements in its periodic reports filed with the Securities and Exchange Commission ("SEC"). QuadraMed’s SEC filings can be accessed through the Investor Relations section of our website, www.quadramed.com, or through the SEC’s EDGAR Database at www.sec.gov (QuadraMed has EDGAR CIK No. 0001018833).
QuadraMed is a registered trademark of QuadraMed Corporation. All other trademarks are the property of their respective holders.
Amendola Communications for QuadraMed Corporation
Jodi Amendola, 480-664-8412, ext. 11
jamendola@ACmarketingPR.com
or
QuadraMed Corporation
David Piazza
Chief Financial Officer
703-742-5393
InvestorRelations@QuadraMed.com
